DrugPatentWatch Database Preview

Ceftriaxone sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ceftriaxone sodium and what is the scope of ceftriaxone sodium freedom to operate?

Ceftriaxone sodium is the generic ingredient in seven branded drugs marketed by Acs Dobfar, Agila Speclts, Aurobindo Pharma Ltd, Bedford, Facta Farma, Fresenius Kabi Usa, Hospira Inc, Lupin, Samson Medcl, Sandoz, Sandoz Inc, Teva, Wockhardt, B Braun, Baxter Hlthcare, Hikma Farmaceutica, Sagent Pharms, Hoffmann La Roche, Roche, Akorn Inc, Cephazone Pharma, Qilu Pharm Co Ltd, and Teva Pharms Usa, and is included in forty NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for ceftriaxone sodium. Twenty-seven suppliers are listed for this compound.

Summary for ceftriaxone sodium

US Patents:	0
Tradenames:	7
Applicants:	23
NDAs:	40
Drug Master File Entries:	25
Suppliers / Packagers:	27
Bulk Api Vendors:	66
Clinical Trials:	12
Patent Applications:	7,486
Formulation / Manufacturing:	see details
DailyMed Link:	ceftriaxone sodium at DailyMed

Pharmacology for ceftriaxone sodium

Ingredient-type	Cephalosporins
Drug Class	Cephalosporin Antibacterial

Medical Subject Heading (MeSH) Categories for ceftriaxone sodium

Anti-Bacterial Agents

Synonyms for ceftriaxone sodium

(6R,7R,)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R,Z)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R,Z)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydra

(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-[[(2E)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium

(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7^2-(Z)-(O-

(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-[1,2,4]triazin-3-ylsulfanylmethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-3-(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-[1,2,4]triazin-3-ylsulfanylmethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(E)-Ceftriaxone Sodium

[6R-[6|A,7|A(Z)]]-7-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt

104376-79-6

104376-79-6 (di-hydrochloride salt)

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, (6R-(6alpha,7beta(Z)))-

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, disodium salt, (6R-(6alpha,7beta(Z

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, (6R,7R)-

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, (6R,7R)-

7-[2-(2-Amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-3-(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-[1,2,4]triazin-3-ylsulfanylmethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid (Ceftriaxone)

7-[2-(2-Amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-3-(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-[1,2,4]triazin-3-ylsulfanylmethyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid(Ceftriaxone)

73384-59-5

74578-69-1

74578-69-1 (di-hydrochloride salt, hemiheptahydrate)

75J73V1629

7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid

AB1009451

AC-1592

AC-1851

AC1NUIFE

AK326214

AKOS015894885

AKOS015960618

AKOS015961150

AN-14520

AN-14762

AN-37256

API0006455

BC203714

BC205730

BDBM50049707

BDBM50103601

Biotrakson

C06683

C18H18N8O7S3

Cefatriaxone

Cefatriaxone hydrate

Cefatriaxone, Antibiotic for Culture Media Use Only

Ceftriaxon

Ceftriaxona

Ceftriaxona [INN-Spanish]

ceftriaxone

Ceftriaxone (INN)

Ceftriaxone (TN)

Ceftriaxone [INN:BAN]

Ceftriaxone [USAN:JAN]

Ceftriaxone and Dextrose in Duplex Container

Ceftriaxone intravenous

Ceftriaxone Sodium [USP]

Ceftriaxone Sodium E-Isomer

Ceftriaxone sodium hydrate

Ceftriaxone sodium salt

CEFTRIAXONE SODIUM TRIHYDRATE

Ceftriaxone, Disodium Salt

Ceftriaxone, Disodium Salt, Hemiheptahydrate

Ceftriaxonesodium

Ceftriaxonum

Ceftriaxonum [INN-Latin]

Ceftriazone

Cephtriaxone

CHEBI:29007

CHEMBL1200995

CHEMBL161

CHEMBL1697718

CS-2948

CTRX

D07659

D07ACT

DB01212

DRG-0071

DTXSID0022773

EINECS 277-405-6

EINECS 277-930-0

HE384190

HY-B0712

I06-164

I06-1763

I06-2130

K250

Longacef

LS-150031

LS-150032

MolPort-002-510-741

MolPort-044-724-672

OCTX

Ro 13-9904

Ro 13-9904/001

Ro 139904

Ro-13-9904

Ro-139904

Ro13-9904

Rocefin

Rocephalin

Rocephin

Rocephin (TN)

Rocephine

Rophex

SC-57984

SCHEMBL23354

SCHEMBL537013

Sodium (6R,7R)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

STOCK1N-08680

STOCK1N-30018

Tartriakson

UNII-75J73V1629

VAAUVRVFOQPIGI-SPQHTLEESA-N

W-104454

X 13-9904

YOBPSXOHCHDCMU-VKZZUTNHSA-M

ZINC8584434

US Patents and Regulatory Information for ceftriaxone sodium

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lupin	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065125-004	Sep 30, 2003	AP	RX	No	No
Roche	ROCEPHIN	ceftriaxone sodium	INJECTABLE;INJECTION	062510-001	Mar 12, 1985		DISCN	No	No
Wockhardt	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065391-003	Apr 12, 2007	AP	RX	No	No
Hospira Inc	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INJECTION	065231-001	Aug 2, 2005		DISCN	No	No
Fresenius Kabi Usa	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065245-004	Feb 15, 2006		DISCN	No	No